These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 4326726

  • 1. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM, Rudoĭ NM.
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract] [Full Text] [Related]

  • 2. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M, Mancini P, Matzeu M.
    Ann Ist Carlo Forlanini; 1968 Feb; 28(1):25-41. PubMed ID: 4314838
    [No Abstract] [Full Text] [Related]

  • 3. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J, Wallace A.
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract] [Full Text] [Related]

  • 4. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T, Motomura K.
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract] [Full Text] [Related]

  • 5. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y.
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract] [Full Text] [Related]

  • 6. Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.
    Canetti G, Gay P, Le Lirzin M.
    Tubercle; 1972 Jun; 53(2):57-83. PubMed ID: 4114335
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Incidence of drug sensitivity decrease in tuberculosis bacteria in untreated tuberculoses using autopsy material].
    Schuh D, Justus J, Wichmann G.
    Z Erkr Atmungsorgane; 1974 Mar; 140(1):91-8. PubMed ID: 4212675
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
    Ibarra JP, Piñeyro J, Trenchi A, Tarallo NH, Lanne de Farriols ME, Cuñarro de Gimeno G, Fernández Latorre I.
    Hoja Tisiol; 1967 Mar; 24(1):5-88. PubMed ID: 4308762
    [No Abstract] [Full Text] [Related]

  • 10. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M, Zwolska-Kwiek Z.
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract] [Full Text] [Related]

  • 11. The effect of radiation on microbiologic characteristics of M tuberculosis.
    Zack MB, Stottmeier K, Berg G, Kazemi H.
    Chest; 1974 Sep; 66(3):240-3. PubMed ID: 4213816
    [No Abstract] [Full Text] [Related]

  • 12. [Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
    Kovalev GK.
    Antibiotiki; 1969 Apr; 14(4):323-5. PubMed ID: 4977639
    [No Abstract] [Full Text] [Related]

  • 13. In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
    Goldstein E, Eagle MC, LaCasse ML.
    Appl Microbiol; 1971 Sep; 22(3):329-33. PubMed ID: 4330314
    [Abstract] [Full Text] [Related]

  • 14. [Correlation between the catalase activity and resistance to drugs in Mycobacterium tuberculosis circulating in Southeast Africa].
    Zykov MP.
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):49-53. PubMed ID: 4295172
    [No Abstract] [Full Text] [Related]

  • 15. Non-photochromogenic mycobacteria serotype Davis. The inhomogeneity within the serological group and the relationship to Mycobacterium avium.
    Engbaek HC, Vergmann B, Baess I.
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970 Mar; 78(5):619-31. PubMed ID: 4322001
    [No Abstract] [Full Text] [Related]

  • 16. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H.
    Acta Biol Med Ger; 1973 Mar; 30(3):309-16. PubMed ID: 4202698
    [No Abstract] [Full Text] [Related]

  • 17. [On the variability of results of sensitivity determination in tuberculosis bacteria].
    Schmiedel A.
    Z Tuberk Erkr Thoraxorg; 1968 Mar; 128(1):238-47. PubMed ID: 4973009
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative determinations of Mycobacterium resistance using the vertical diffusion test and the proportion method (economical test)].
    Kalich R, Nitschke M, Ulber H, Mydlak G, Werner E, Gerloff W, Reinhold L.
    Z Erkr Atmungsorgane; 1974 Mar; 140(3):242-52. PubMed ID: 4142152
    [No Abstract] [Full Text] [Related]

  • 19. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid].
    Rudnicka M, Suszko K.
    Med Dosw; 1966 Mar; 33():291-302. PubMed ID: 4287506
    [No Abstract] [Full Text] [Related]

  • 20. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP.
    Probl Tuberk; 1970 Mar; 48(9):76-9. PubMed ID: 4996497
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.